207 related articles for article (PubMed ID: 16182810)
1. Impact of homocysteinemia on long-term renal transplant survival.
Fonseca I; Martins L; Queirós J; Mendonça D; Dias L; Sarmento AM; Henriques AC; Cabrita A
Transplant Proc; 2005; 37(6):2784-8. PubMed ID: 16182810
[TBL] [Abstract][Full Text] [Related]
2. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.
Winkelmayer WC; Kramar R; Curhan GC; Chandraker A; Endler G; Födinger M; Hörl WH; Sunder-Plassmann G
J Am Soc Nephrol; 2005 Jan; 16(1):255-60. PubMed ID: 15563562
[TBL] [Abstract][Full Text] [Related]
3. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
[TBL] [Abstract][Full Text] [Related]
4. Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients.
Hjelmesaeth J; Ueland T; Flyvbjerg A; Bollerslev J; Leivestad T; Jenssen T; Hansen TK; Thiel S; Sagedal S; Røislien J; Hartmann A
J Am Soc Nephrol; 2006 Jun; 17(6):1746-54. PubMed ID: 16687626
[TBL] [Abstract][Full Text] [Related]
5. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival.
Bestard O; Cruzado JM; Torras J; Gil-Vernet S; Serón D; Moreso F; Rama I; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3774-7. PubMed ID: 16386535
[TBL] [Abstract][Full Text] [Related]
7. Effect of MTHFR genotypes and hyperhomocysteinemia on patient and graft survival in kidney transplant recipients.
Hagen W; Födinger M; Heinz G; Buchmayer H; Hörl WH; Sunder-Plassmann G
Kidney Int Suppl; 2001 Feb; 78():S253-7. PubMed ID: 11169021
[TBL] [Abstract][Full Text] [Related]
8. The first year renal function as a predictor of long-term graft survival after kidney transplantation.
Helal I; Abderrahim E; Ben Hamida F; Ounissi M; Essine S; Hedri H; Bardi R; Elgorgi Y; El Younsi F; Ben Maiz H; Ben Abdallah T; Kheder A
Transplant Proc; 2009 Mar; 41(2):648-50. PubMed ID: 19328945
[TBL] [Abstract][Full Text] [Related]
9. Serum total homocysteine concentration does not predict outcome in renal transplant recipients.
Dimény E; Hultberg B; Wahlberg J; Fellström B; Arnadottir M
Clin Transplant; 1998 Dec; 12(6):563-8. PubMed ID: 9850451
[TBL] [Abstract][Full Text] [Related]
10. The impact of donor spontaneous intracranial haemorrhage vs. other donors on long-term renal graft and patient survival.
Johnston O; O'Kelly P; Spencer S; Cunningham P; Dorman A; Donohoe J; Walshe JJ; Hickey D; Little DM; Conlon PJ
Clin Transplant; 2006; 20(1):91-5. PubMed ID: 16556161
[TBL] [Abstract][Full Text] [Related]
11. Patient mortality after graft failure reduces kidney transplant patient survival only in the long term: an "intention to treat" analysis.
Maffei C; Sandrini S; Galanopoulou A; Bossini N; Setti G; Iovinella L; Turina S; Cancarini G
Transplant Proc; 2008; 40(6):1862-4. PubMed ID: 18675071
[TBL] [Abstract][Full Text] [Related]
12. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
Oterdoom LH; van Ree RM; de Vries AP; Gansevoort RT; Schouten JP; van Son WJ; Homan van der Heide JJ; Navis G; de Jong PE; Gans RO; Bakker SJ
Transplantation; 2008 Aug; 86(3):391-8. PubMed ID: 18698241
[TBL] [Abstract][Full Text] [Related]
13. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
Weiss ES; Nwakanma LU; Patel ND; Yuh DD
J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
[TBL] [Abstract][Full Text] [Related]
15. Impact of donor age on renal allograft function and survival.
Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
Transplant Proc; 2009 Apr; 41(3):794-6. PubMed ID: 19376354
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum phosphate predicts mortality in renal transplant recipients.
Connolly GM; Cunningham R; McNamee PT; Young IS; Maxwell AP
Transplantation; 2009 Apr; 87(7):1040-4. PubMed ID: 19352125
[TBL] [Abstract][Full Text] [Related]
17. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.
Mitsnefes MM; Khoury PR; McEnery PT
J Pediatr; 2003 Jul; 143(1):98-103. PubMed ID: 12915832
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
Foley DP; Patton PR; Meier-Kriesche HU; Li Q; Shenkman B; Fujita S; Reed A; Hemming AW; Kim RD; Howard RJ
Clin Transpl; 2005; ():101-9. PubMed ID: 17424728
[TBL] [Abstract][Full Text] [Related]
19. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
Manga Sahin G; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
